oseltamivir has been researched along with Anoxemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akat, H; Laloglu, F; Orbak, Z | 1 |
| Chiba, S | 1 |
| Bender, M; Bernheisel, C | 1 |
| Chowers, M; Hiba, V; Leibovici, L; Levi-Vinograd, I; Paul, M; Rubinovitch, B | 1 |
| Amith, SR; Contreras, R; Davis, VW; De Vusser, K; Jayanth, P; Laroy, W; Meakin, SO; Szewczuk, MR; Woronowicz, A | 1 |
5 other study(ies) available for oseltamivir and Anoxemia
| Article | Year |
|---|---|
Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.
Topics: Ampicillin; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Child; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Drug Combinations; Enoxaparin; Humans; Hydroxychloroquine; Hypoxia; Immunoglobulins, Intravenous; Immunologic Factors; Lopinavir; Lung; Male; Mucocutaneous Lymph Node Syndrome; Oseltamivir; Oxygen Inhalation Therapy; Ritonavir; Sulbactam; Tomography, X-Ray Computed | 2021 |
Effect of early oseltamivir on outpatients without hypoxia with suspected COVID-19.
Topics: Adult; Antiviral Agents; China; COVID-19; Female; Humans; Hypoxia; Influenza, Human; Male; Middle Aged; Oseltamivir; Outpatients; SARS-CoV-2 | 2021 |
Fever, cough, and hypoxia in a pregnant woman.
Topics: Adult; Antiviral Agents; Cough; Female; Fever; Humans; Hypoxia; Influenza A Virus, H1N1 Subtype; Oseltamivir; Oxygen Inhalation Therapy; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Respiratory Distress Syndrome; Vomiting | 2010 |
Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cohort Studies; Critical Care; Female; Hospitalization; Humans; Hypoxia; Influenza A Virus, H1N1 Subtype; Influenza, Human; Israel; Male; Middle Aged; Oseltamivir; Pneumonia, Bacterial; Respiration, Artificial; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult | 2011 |
Trypanosome trans-sialidase mediates neuroprotection against oxidative stress, serum/glucose deprivation, and hypoxia-induced neurite retraction in Trk-expressing PC12 cells.
Topics: Animals; Cell Survival; Enzyme Inhibitors; Glial Cell Line-Derived Neurotrophic Factor; Glucose; Glycoproteins; Hypoxia; Nerve Growth Factor; Neuraminidase; Oseltamivir; Oxidative Stress; PC12 Cells; Rats; Receptor, trkB; Serum; Trypanosoma cruzi | 2007 |